Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retrovirus classification and cell interactions

R A Weiss1

  • 1Institute of Cancer Research, Chester Beatty Laboratories, London, UK.

The Journal of Antimicrobial Chemotherapy
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fabrication of Tough Double-Network Hydrogels from Highly Cross-Linked Brittle Neutral Networks Using Alkaline Hydrolysis.

Gels (Basel, Switzerland)·2024
Same author

Consolidation and Forced Elasticity in Double-Network Hydrogels.

Gels (Basel, Switzerland)·2023
Same author

Facile Fabrication of a Shape Memory Polymer by Swelling Cross-Linked Natural Rubber with Stearic Acid.

ACS macro letters·2022
Same author

Mechanically Tough, Thermally Activated Shape Memory Hydrogels.

ACS macro letters·2022
Same author

Sulfonation Distribution in Sulfonated Polystyrene Ionomers Measured by MALDI-ToF MS.

ACS macro letters·2022
Same author

Brittle-to-Ductile Transition of Sulfonated Polystyrene Ionomers.

ACS macro letters·2022
Same journal

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same journal

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same journal

Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

The Journal of antimicrobial chemotherapy·2026
Same journal

Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

The Journal of antimicrobial chemotherapy·2026
See all related articles

Retroviruses cause diseases like cancer and AIDS, but some are harmless or inherited. Their cell interactions dictate disease, and they are used in gene therapy.

Area of Science:

  • * Virology and retrovirology.
  • * Molecular biology and pathogenesis.
  • * Gene therapy and vector development.

Background:

  • * Retroviruses are a diverse group of viruses with varied impacts on hosts.
  • * Diseases associated with retroviruses include cancer, AIDS, autoimmunity, and neurological disorders.
  • * Some retroviral genomes are integrated into host DNA as mendelian traits.

Purpose of the Study:

  • * To review the diverse roles of retroviruses in disease and therapy.
  • * To highlight the importance of cell interactions in retroviral pathogenesis.
  • * To discuss the therapeutic applications of retroviruses in gene therapy.

Main Methods:

  • * Literature review of retroviral research.
  • * Analysis of retroviral pathogenesis mechanisms.

Related Experiment Videos

  • * Examination of retroviral vector applications in gene therapy.

    • Main Results:

    • * Retroviruses are implicated in a spectrum of diseases, from cancer to neurological conditions.
    • * Viral load and cell interactions are key determinants of retroviral disease severity.
    • * Therapeutic exploitation of retroviruses as gene therapy vectors is a growing field.

    Conclusions:

    • * Retroviruses present a complex biological profile, ranging from pathogenic to benign.
    • * Understanding retroviral cell interactions is crucial for deciphering pathogenesis.
    • * Retroviruses hold significant promise for innovative gene therapy strategies.